Antivenom Market in Germany - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 91 pages | ID: A34E1B040BF4EN
Market Monitor Global

Abstracts

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
This report contains market size and forecasts of Antivenom in Germany, including the following market information:
Germany Antivenom Market Revenue, 2015-2020, 2021-2026, ($ millions)
Germany Antivenom Market Consumption, 2015-2020, 2021-2026, (K Vials)
Germany Antivenom Production Capacity, 2015-2020, 2021-2026, (K Vials)
Top Five Competitors in Germany Antivenom Market 2019 (%)
The global Antivenom market was valued at 898.9 million in 2019 and is projected to reach US$ 991.8 million by 2026, at a CAGR of 2.5% during the forecast period. While the Antivenom market size in Germany was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antivenom manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Antivenom production and consumption in Germany

Total Market by Segment:

Germany Antivenom Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Vials)
Germany Antivenom Market Segment Percentages, By Type, 2019 (%)

• Polyvalent antivenom
• Monovalent antivenom

Germany Antivenom Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Vials)
Germany Antivenom Market Segment Percentages, By Application, 2019 (%)

• Retail Pharmacies
• Hospitals
• Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Antivenom Market Competitors Revenues in Germany, by Players 2015-2020 (Estimated), ($ millions)
Total Antivenom Market Competitors Revenues Share in Germany, by Players 2019 (%)
Total Germany Antivenom Market Competitors Sales, by Players 2015-2020 (Estimated), (K Vials)
Total Germany Antivenom Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:

• CSL Behring
• Merck & Co.
• BTG Plc
• Pfizer
• Haffkine Bio-Pharmaceutical Corporation
• Rare Disease Therapeutics
• Flynn Pharma
• Vins Bioproducts
• Bharat Serums and Vaccines

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antivenom Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Germany Antivenom Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: GERMANY ANTIVENOM OVERALL MARKET SIZE

2.1 Germany Antivenom Market Size: 2020 VS 2026
2.2 Germany Antivenom Revenue, Prospects & Forecasts: 2015-2026
2.3 Germany Antivenom Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Antivenom Players in Germany (including Foreign and Local Companies)
3.2 Top Germany Antivenom Companies Ranked by Revenue
3.3 Germany Antivenom Revenue by Companies (including Foreign and Local Companies)
3.4 Germany Antivenom Sales by Companies (including Foreign and Local Companies)
3.5 Germany Antivenom Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Antivenom Companies in Germany, by Revenue in 2019
3.7 Germany Manufacturers Antivenom Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antivenom Players in Germany
  3.8.1 List of Germany Tier 1 Antivenom Companies
  3.8.2 List of Germany Tier 2 and Tier 3 Antivenom Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Germany Antivenom Market Size Markets, 2020 & 2026
  4.1.2 Polyvalent antivenom
  4.1.3 Monovalent antivenom
4.2 By Type - Germany Antivenom Revenue & Forecasts
  4.2.1 By Type - Germany Antivenom Revenue, 2015-2020
  4.2.2 By Type - Germany Antivenom Revenue, 2021-2026
  4.2.3 By Type - Germany Antivenom Revenue Market Share, 2015-2026
4.3 By Type - Germany Antivenom Sales & Forecasts
  4.3.1 By Type - Germany Antivenom Sales, 2015-2020
  4.3.2 By Type - Germany Antivenom Sales, 2021-2026
  4.3.3 By Type - Germany Antivenom Sales Market Share, 2015-2026
4.4 By Type - Germany Antivenom Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Germany Antivenom Market Size, 2020 & 2026
  5.1.2 Retail Pharmacies
  5.1.3 Hospitals
  5.1.4 Others
5.2 By Application - Germany Antivenom Revenue & Forecasts
  5.2.1 By Application - Germany Antivenom Revenue, 2015-2020
  5.2.2 By Application - Germany Antivenom Revenue, 2021-2026
  5.2.3 By Application - Germany Antivenom Revenue Market Share, 2015-2026
5.3 By Application - Germany Antivenom Sales & Forecasts
  5.3.1 By Application - Germany Antivenom Sales, 2015-2020
  5.3.2 By Application - Germany Antivenom Sales, 2021-2026
  5.3.3 By Application - Germany Antivenom Sales Market Share, 2015-2026
5.4 By Application - Germany Antivenom Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 CSL Behring
  6.1.1 CSL Behring Corporate Summary
  6.1.2 CSL Behring Business Overview
  6.1.3 CSL Behring Antivenom Major Product Offerings
  6.1.4 CSL Behring Sales and Revenue in Germany (2015-2020)
  6.1.5 CSL Behring Key News
6.2 Merck & Co.
  6.2.1 Merck & Co. Corporate Summary
  6.2.2 Merck & Co. Business Overview
  6.2.3 Merck & Co. Antivenom Major Product Offerings
  6.2.4 Merck & Co. Sales and Revenue in Germany (2015-2020)
  6.2.5 Merck & Co. Key News
6.3 BTG Plc
  6.3.1 BTG Plc Corporate Summary
  6.3.2 BTG Plc Business Overview
  6.3.3 BTG Plc Antivenom Major Product Offerings
  6.3.4 BTG Plc Sales and Revenue in Germany (2015-2020)
  6.3.5 BTG Plc Key News
6.4 Pfizer
  6.4.1 Pfizer Corporate Summary
  6.4.2 Pfizer Business Overview
  6.4.3 Pfizer Antivenom Major Product Offerings
  6.4.4 Pfizer Sales and Revenue in Germany (2015-2020)
  6.4.5 Pfizer Key News
6.5 Haffkine Bio-Pharmaceutical Corporation
  6.5.1 Haffkine Bio-Pharmaceutical Corporation Corporate Summary
  6.5.2 Haffkine Bio-Pharmaceutical Corporation Business Overview
  6.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Major Product Offerings
  6.5.4 Haffkine Bio-Pharmaceutical Corporation Sales and Revenue in Germany (2015-2020)
  6.5.5 Haffkine Bio-Pharmaceutical Corporation Key News
6.6 Rare Disease Therapeutics
  6.6.1 Rare Disease Therapeutics Corporate Summary
  6.6.2 Rare Disease Therapeutics Business Overview
  6.6.3 Rare Disease Therapeutics Antivenom Major Product Offerings
  6.6.4 Rare Disease Therapeutics Sales and Revenue in Germany (2015-2020)
  6.6.5 Rare Disease Therapeutics Key News
6.7 Flynn Pharma
  6.6.1 Flynn Pharma Corporate Summary
  6.6.2 Flynn Pharma Business Overview
  6.6.3 Flynn Pharma Antivenom Major Product Offerings
  6.4.4 Flynn Pharma Sales and Revenue in Germany (2015-2020)
  6.7.5 Flynn Pharma Key News
6.8 Vins Bioproducts
  6.8.1 Vins Bioproducts Corporate Summary
  6.8.2 Vins Bioproducts Business Overview
  6.8.3 Vins Bioproducts Antivenom Major Product Offerings
  6.8.4 Vins Bioproducts Sales and Revenue in Germany (2015-2020)
  6.8.5 Vins Bioproducts Key News
6.9 Bharat Serums and Vaccines
  6.9.1 Bharat Serums and Vaccines Corporate Summary
  6.9.2 Bharat Serums and Vaccines Business Overview
  6.9.3 Bharat Serums and Vaccines Antivenom Major Product Offerings
  6.9.4 Bharat Serums and Vaccines Sales and Revenue in Germany (2015-2020)
  6.9.5 Bharat Serums and Vaccines Key News
6.10 Serum Biotech
  6.10.1 Serum Biotech Corporate Summary
  6.10.2 Serum Biotech Business Overview
  6.10.3 Serum Biotech Antivenom Major Product Offerings
  6.10.4 Serum Biotech Sales and Revenue in Germany (2015-2020)
  6.10.5 Serum Biotech Key News

7 ANTIVENOM PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Antivenom Production Capacity and Value in Germany, Situation Analysis and Prediction, 2015-2026
  7.1.1 Germany Antivenom Production Capacity, 2015-2026
  7.1.2 Germany Antivenom Production 2015-2026
  7.1.3 Germany Antivenom Production Value 2015-2026
7.2 Key Local Antivenom Manufacturers in Germany
  7.2.1 Germany Key Local Antivenom Manufacturers Production Capacity
  7.2.2 Germany Key Local Antivenom Manufacturers Production
  7.2.3 Germany Key Local Antivenom Manufacturers Production Value
  7.2.4 The Proportion of Antivenom Production Sold in Germany and Sold Other Than Germany by Manufacturers
7.3 Antivenom Export and Import in Germany
  7.3.1 Germany Antivenom Export Market
  7.3.2 Germany Antivenom Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Germany Antivenom Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON ANTIVENOM SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Antivenom Distributors and Sales Agents in Germany

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Antivenom in Germany
Table 2. Top Players in Germany, Ranking by Revenue (2019)
Table 3. Germany Antivenom Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Germany Antivenom Revenue Share by Companies, 2015-2020
Table 5. Germany Antivenom Sales by Companies, (K Vials), 2015-2020
Table 6. Germany Antivenom Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Antivenom Price (2015-2020) (USD/Vial)
Table 8. Germany Manufacturers Antivenom Product Type
Table 9. List of Germany Tier 1 Antivenom Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Germany Tier 2 and Tier 3 Antivenom Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Antivenom Revenue in Germany (US$, Mn), 2015-2020
Table 12. By Type - Antivenom Revenue in Germany (US$, Mn), 2021-2026
Table 13. By Type - Antivenom Sales in Germany (K Vials), 2015-2020
Table 14. By Type - Antivenom Sales in Germany (K Vials), 2021-2026
Table 15. By Application - Antivenom Revenue in Germany, (US$, Mn), 2015-2020
Table 16. By Application - Antivenom Revenue in Germany, (US$, Mn), 2021-2026
Table 17. By Application - Antivenom Sales in Germany, (K Vials), 2015-2020
Table 18. By Application - Antivenom Sales in Germany, (K Vials), 2021-2026
Table 19. CSL Behring Corporate Summary
Table 20. CSL Behring Antivenom Product Offerings
Table 21. CSL Behring Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 22. Merck & Co. Corporate Summary
Table 23. Merck & Co. Antivenom Product Offerings
Table 24. Merck & Co. Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 25. BTG Plc Corporate Summary
Table 26. BTG Plc Antivenom Product Offerings
Table 27. BTG Plc Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 28. Pfizer Corporate Summary
Table 29. Pfizer Antivenom Product Offerings
Table 30. Pfizer Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 31. Haffkine Bio-Pharmaceutical Corporation Corporate Summary
Table 32. Haffkine Bio-Pharmaceutical Corporation Antivenom Product Offerings
Table 33. Haffkine Bio-Pharmaceutical Corporation Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 34. Rare Disease Therapeutics Corporate Summary
Table 35. Rare Disease Therapeutics Antivenom Product Offerings
Table 36. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 37. Flynn Pharma Corporate Summary
Table 38. Flynn Pharma Antivenom Product Offerings
Table 39. Flynn Pharma Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 40. Vins Bioproducts Corporate Summary
Table 41. Vins Bioproducts Antivenom Product Offerings
Table 42. Vins Bioproducts Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 43. Bharat Serums and Vaccines Corporate Summary
Table 44. Bharat Serums and Vaccines Antivenom Product Offerings
Table 45. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 46. Serum Biotech Corporate Summary
Table 47. Serum Biotech Antivenom Product Offerings
Table 48. Serum Biotech Antivenom Sales (K Vials), Revenue (US$, Mn) and Average Price (USD/Vial) (2015-2020)
Table 49. Antivenom Production Capacity (K Vials) of Local Manufacturers in Germany, 2015-2020
Table 50. Antivenom Production (K Vials) of Local Manufacturers in Germany, 2015-2020
Table 51. Germany Antivenom Production Market Share of Local Manufacturers, 2015-2020
Table 52. Antivenom Production Value (US$, Mn) of Local Manufacturers in Germany, 2015-2020
Table 53. Germany Antivenom Production Value Market Share of Local Manufacturers, 2015-2020
Table 54. The Percentage of Antivenom Production Sold in Germany and Sold Other Than Germany by Manufacturers
Table 55. The Percentage of Antivenom Production Sold in Germany and Sold Other Than Germany by Manufacturers
Table 56. Dangeguojia Antivenom Sales (Consumption), Production, Export and Import, 2015-2020
Table 57. Raw Materials and Suppliers
Table 58. Antivenom Downstream Clients in Germany
Table 59. Antivenom Distributors and Sales Agents in Germany

List Of Figures

LIST OF FIGURES

Figure 1. Antivenom Segment by Type
Figure 2. Antivenom Segment by Application
Figure 3. Dangeguojia Antivenom Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Antivenom Market Size in Germany, (US$, Mn) & (K Vials): 2020 VS 2026
Figure 6. Germany Antivenom Revenue, 2015-2026 (US$, Mn)
Figure 7. Antivenom Sales in Germany: 2015-2026 (K Vials)
Figure 8. The Top 3 and 5 Players Market Share by Antivenom Revenue in 2019
Figure 9. By Type - Germany Antivenom Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Germany Antivenom Market Share, 2015-2020
Figure 11. By Type - Germany Antivenom Market Share, 2020-2026
Figure 12. By Type - Germany Antivenom Price (USD/Vial), 2015-2026
Figure 13. By Application - Antivenom Revenue in Germany (US$, Mn), 2020 & 2026
Figure 14. By Application - Germany Antivenom Market Share, 2015-2020
Figure 15. By Application - Germany Antivenom Market Share, 2020-2026
Figure 16. By Application -Germany Antivenom Price (USD/Vial), 2015-2026
Figure 17. Germany Antivenom Production Capacity (K Vials), 2015-2026
Figure 18. Germany Antivenom Actual Output (K Vials), 2015-2026
Figure 19. Germany Antivenom Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Germany Antivenom Export Destination, 2019
Figure 21. The Source of Imports of Germany Antivenom, 2019
Figure 22. PEST Analysis for Germany Antivenom Market in 2020
Figure 23. Antivenom Market Opportunities & Trends in Germany
Figure 24. Antivenom Market Drivers in Germany
Figure 25. Antivenom Market Restraints in Germany
Figure 26. Antivenom Industry Value Chain